Evidence map›Paper›PMID 30089680›Full record

Trial reportCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2018

Electronic Medical Alerts Increase Screening for Chronic Hepatitis B: A Randomized, Double-Blind, Controlled Trial.

Eric Chak, Amir Taefi, Chin-Shang Li, Moon S Chen, Aaron M Harris, Scott MacDonald, Christopher Bowlus

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 4 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 4 syntheses or guidelines pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    Guideline
  4. Pooled it
  5. A Best Practice Alert for Identifying Hepatitis B-Infected Patients.The American journal of tropical medicine and hygiene · 2020
    Trial
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Improved Diabetes Screening for Women After Gestational Diabetes Mellitus.Diabetes spectrum : a publication of the American Diabetes Association · 2025
    Article
  12. Article
  13. Impact of universal hepatitis B virus (HBV) screening using chemotherapy orders on the HBV reactivation in cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Observational
  14. Article
  15. Article
  16. Clinical Decision Support Systems for Diagnosis in Primary Care: A Scoping Review.International journal of environmental research and public health · 2021
    Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Eric ChakUC Davis School of Medicine, Division of Gastroenterology and Hepatology, Sacramento, California. echak@ucdavis.edu.
Amir TaefiUC Davis School of Medicine, Division of Gastroenterology and Hepatology, Sacramento, California.
Chin-Shang LiDivision of Biostatistics, Department of Public Health Sciences, School of Medicine, University of California, Davis.
Moon S ChenUC Davis School of Medicine, Division of Hematology and Oncology, Sacramento, California.
Aaron M HarrisDivision of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia.ORCID 0000-0001-7121-7635
Scott MacDonaldUC Davis Medical Center, Division of Clinical Informatics.
Christopher BowlusUC Davis School of Medicine, Division of Gastroenterology and Hepatology, Sacramento, California.ORCID 0000-0002-3906-6811
University of California Davis Medical Center · USCenters for Disease Control and Prevention · USDepartment of Public Health · US

Funding

UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
SACRAMENTO COLLABORATIVE TO ADVANCE TESTING AND CARE OF HEPATITIS B (SCRATCH)U51PS004633 · PS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BOWLUS, CHRISTOPHER L. · 2014 to 2015
$627k
NCATS NIH HHS UL1 TR001860NCHHSTP CDC HHS U51 PS004633
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Double-Blind MethodElectronic Health RecordsFemaleHepatitis B, ChronicHumansMaleMass Screening

Identifiers

PMID30089680
PMCPMC6214733
OpenAlexW2885059697

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.